GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » resTORbio Inc (NAS:TORC) » Definitions » Tangible Book per Share

resTORbio (resTORbio) Tangible Book per Share : $13.59 (As of Jun. 2020)


View and export this data going back to 2018. Start your Free Trial

What is resTORbio Tangible Book per Share?

Tangible book value per share is calculated as the total tangible equity divided by Shares Outstanding (EOP). Total tangible equity is calculated as the Total Stockholders Equity minus Preferred Stock minus Intangible Assets. resTORbio's tangible book value per share for the quarter that ended in Jun. 2020 was $13.59.

Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.


resTORbio Tangible Book per Share Historical Data

The historical data trend for resTORbio's Tangible Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

resTORbio Tangible Book per Share Chart

resTORbio Annual Data
Trend Dec16 Dec17 Dec18 Dec19
Tangible Book per Share
- -8.22 26.00 15.69

resTORbio Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Tangible Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.81 21.08 15.69 14.52 13.59

Competitive Comparison of resTORbio's Tangible Book per Share

For the Biotechnology subindustry, resTORbio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


resTORbio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, resTORbio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where resTORbio's Price-to-Tangible-Book falls into.



resTORbio Tangible Book per Share Calculation

resTORbio's Tangible Book Value Per Share for the fiscal year that ended in Dec. 2019 is calculated as

Tangible Book Value per Share=(Total Stockholders Equity-Preferred Stock-Intangible Assets)/Shares Outstanding (EOP)
=(81.698-0-0)/5.20638
=15.69

resTORbio's Tangible Book Value Per Share for the quarter that ended in Jun. 2020 is calculated as

Tangible Book Value per Share=(Total Stockholders Equity-Preferred Stock-Intangible Assets)/Shares Outstanding (EOP)
=(70.744-0-0)/5.20669
=13.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total equity is a balance sheet item and equal to total assets less total liabilities of the company. Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.


resTORbio  (NAS:TORC) Tangible Book per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


resTORbio Tangible Book per Share Related Terms

Thank you for viewing the detailed overview of resTORbio's Tangible Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


resTORbio (resTORbio) Business Description

Traded in Other Exchanges
N/A
Address
500 Boylston Street, 13th Floor, Boston, MA, USA, 02116
resTORbio Inc is a clinical-stage biopharmaceutical company. It mainly focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. The company focuses on the mechanistic target of rapamycin (mTOR) pathway which regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1. It is also involved in the development of RTB101 which is a small molecule, potent TORC1 inhibitor. The company's pipeline products include RTB101 and RTB101+ everolimus.